Brown M S, Goldstein J L
Proc Natl Acad Sci U S A. 1974 Mar;71(3):788-92. doi: 10.1073/pnas.71.3.788.
Monolayers of cultured fibroblasts from normal human subjects bind (125)I-labeled low-density lipoproteins with high affinity and specificity. High affinity binding of similar magnitude was not observed in cells from five unrelated subjects with the homozygous form of familial hypercholesterolemia. In normal cells incubated at 37 degrees , the binding sites were saturated at a low-density lipoprotein concentration of 20 mug/ml. A maximum of approximately 250,000 molecules could be bound to each cell. Whole serum and very-low-density lipoproteins displaced (125)I-labeled low-density lipoproteins from the binding sites, but high-density lipoproteins, the lipoprotein-deficient fraction of serum, and abetalipoproteinemic serum did not. This binding appears to be a required step in the process by which low-density lipoproteins normally suppress the synthesis of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase, the rate-controlling enzyme in cholesterol biosynthesis. The demonstration of a defect in binding of low-density lipoproteins to cells from subjects with the homozygous form of familial hypercholesterolemia appears to explain the previously reported failure of lipoproteins to suppress the synthesis of this enzyme and hence may account for the overproduction of cholesterol that occurs in these cultured cells.
来自正常人类受试者的培养成纤维细胞单层以高亲和力和特异性结合(125)I标记的低密度脂蛋白。在患有纯合子型家族性高胆固醇血症的五名无关受试者的细胞中未观察到类似程度的高亲和力结合。在37摄氏度下培养的正常细胞中,低密度脂蛋白浓度为20微克/毫升时结合位点饱和。每个细胞最多可结合约250,000个分子。全血清和极低密度脂蛋白可将(125)I标记的低密度脂蛋白从结合位点上置换下来,但高密度脂蛋白、血清的脂蛋白缺陷部分和无β脂蛋白血症血清则不能。这种结合似乎是低密度脂蛋白正常抑制3-羟基-3-甲基戊二酰辅酶A还原酶(胆固醇生物合成中的限速酶)合成过程中的一个必要步骤。纯合子型家族性高胆固醇血症患者细胞中低密度脂蛋白结合缺陷的证明似乎解释了先前报道的脂蛋白不能抑制该酶合成的现象,因此可能解释了这些培养细胞中胆固醇的过度产生。